# Da Linghaowan Ceyuan Fund

> Da Linghaowan Ceyuan Fund is a VC fund backing Diabetes, Health Care and Manufacturing. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 3
- Last investment: Apr 2026
- Lead investor: 67%
- Last updated: Aug 2026

Da Linghaowan Ceyuan Fund is an investment firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Diabetes | 1 | 33% |
| Health Care | 1 | 33% |
| Manufacturing | 1 | 33% |
| Advanced Materials | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 67% |
| Series B | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Bailing Aerospace | Bailing Aerospace is a microsatellite developer focused on satellite design, core product R&D, and integrated assembly and testing capabilities, delivering end-to-end solutions that support the full satellite lifecycle from concept development and engineering to manufacturing, validation, and deployment for a wide range of space applications. |  | Series A | Apr 20, 2026 |  |
| Hengfeng New Materials | Hengfeng New Materials is a producer of electronic-grade phenolic resin and distinctive epoxy resin. | $14.4M | Series B | Jan 27, 2026 |  |
| Zhixin Haozheng | Zhixin Haozheng is an inventor of regenerating islet technology. The company focuses on in vitro regeneration of human tissues and organs, with the major pipeline consisting of regenerative islets that can be implanted to cure diabetes. | $13.7M | Series A | May 06, 2025 |  |

3 of 3 investments shown.

## Co-investors
- CRRC Capital — VC Fund, 1 deal together
- [Glory Ventures](https://shizune.co/investors/profile/glory-ventures) — VC Fund, 1 deal together
- [Hua Capital](https://shizune.co/investors/profile/hua-capital) — VC Fund, 1 deal together
- Lingang Digital Technology Fund — VC Fund, 1 deal together
- Shanghai STVC Group — VC Fund, 1 deal together
- [Yangtze River Delta Research Institute](https://shizune.co/investors/profile/yangtze-river-delta-research-institute) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Da Linghaowan Ceyuan Fund invest in?

Da Linghaowan Ceyuan Fund invests primarily in Diabetes, Health Care and Manufacturing startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Da Linghaowan Ceyuan Fund last invest?

The most recent investment recorded for Da Linghaowan Ceyuan Fund closed in Apr 2026. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co